Clinical Trials Directory

Trials / Completed

CompletedNCT01291589

HIV Prevention in Very High Risk Men Who Have Sex With Men

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Fenway Community Health · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to pilot test an innovative program development project in an open trial format an 8-session, individual, cognitive-behavioral therapy based, intervention on ten (10) HIV-infected men who have sex with men who report very high levels (\>10 episodes) of sexual transmission risk behavior (unprotected anal intercourse with serodiscordant partners).

Detailed description

This is an innovative program development project that will, over the next year, pilot test, in an open trial format an 8-session, individual, cognitive-behavioral therapy based, intervention on ten (10) HIV-infected men who have sex with men who report very high levels (\>10 episodes) of sexual transmission risk behavior (unprotected anal intercourse with serodiscordant partners). That is, to pilot test a novel prevention intervention designed to effect reductions in sexual transmission risk behavior among the riskiest men in the largest HIV risk group in the US. Effecting even modest reductions in the mean number of risk acts in this group will likely have substantial public health significance through the number of averted new HIV infections. Traditional secondary HIV intervention strategies (e.g., Information, Motivation, Behavior change (IMB)) models only have modest effects for HIV-positive MSM and there is evidence to suggest that these effects tend to diminish over time.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive-behavioral therapyTreatment will include elements from effective interventions for reducing risky sexual behaviors

Timeline

Start date
2011-11-01
Primary completion
2012-04-01
Completion
2012-09-01
First posted
2011-02-08
Last updated
2016-08-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01291589. Inclusion in this directory is not an endorsement.